Search Login Register

tumor-associated transplantation antigen (TSTA) Summary

Description: over 94% identical with tum- antigen P198; found in fractions derived from cytosol of the Meth A sarcoma cells; chemically induced neoplasms contain individually distinct TATA; are immunogenic in their syngeneic hosts & provide transplantation immunity only to their respective tumors & not similarly induced tumors

Also Known As: TSTA; Meth A antigen; p23 transplantation antigen; tumor-specific transplantation antigen

Networked: 143 relevant articles (11 outcomes, 16 trials/studies) for this Bio-Agent

Key Diseases for which tumor-associated transplantation antigen is Relevant

  1. Neoplasms (Cancer) : 8 outcomes 9 studies in 102 results
  2. Neoplasm Metastasis (Metastasis) : 2 outcomes in 9 results
  3. Prostatic Neoplasms (Prostate Cancer) : 2 outcomes in 6 results
  4. Sarcoma (Soft Tissue Sarcoma) : 1 outcome 3 studies in 29 results
  5. Fibrosarcoma : 1 outcome 1 study in 18 results
Show All >>

Drugs Related to tumor-associated transplantation antigen

  1. Methylcholanthrene
  2. Telomerase (Telomerase Reverse Transcriptase)
  3. Histocompatibility Antigens (Histocompatibility Antigen)
  4. Interleukin-2 (IL2)
  5. Gal-VP16
  6. telomerase RNA (bTR)
  7. Antigens
  8. tumor-associated transplantation antigen (TSTA)
  9. Caspase 3 (Caspase-3)
  10. Histocompatibility Antigens Class I
Show All >>

Therapies Related to tumor-associated transplantation antigen

  1. Transplantation (Transplant Recipients)
  2. Injections
  3. Heterologous Transplantation (Xenotransplantation)
  4. Amputation
  5. Transplants (Transplant)
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.